Search research articles
Contact Us
Filters
Showing results (221-230 of 231) with videos related to
Page
of 24
Sort By:
Journal of Medicinal Chemistry
|
June 17, 2016
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1)
John L Gilmore, James E Sheppeck, Scott H Watterson, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 9, 2016
Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1)
Junqing Guo, Scott H Watterson, Steven H Spergel, et al.
Journal of Medicinal Chemistry
|
March 10, 2009
Novel tricyclic inhibitors of IkappaB kinase
James Kempson, Steven H Spergel, Junqing Guo, et al.
Journal of Medicinal Chemistry
|
May 17, 2002
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity
T G Murali Dhar, Zhongqi Shen, Junqing Guo, et al.
Scientific Reports
|
March 4, 2025
Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension
Shan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Scientific Reports
|
June 8, 2024
Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension
Shan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Journal of Medicinal Chemistry
|
July 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
Stephen T Wrobleski, Ryan Moslin, Shuqun Lin, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products
J V Duncia, J B Santella, C A Higley, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies
|
November 5, 2013
Aging as accelerated accumulation of somatic variants: whole-genome sequencing of centenarian and middle-aged monozygotic twin pairs
Kai Ye, Marian Beekman, Eric-Wubbo Lameijer, et al.
Journal of Medicinal Chemistry
|
April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
Heidi L Perez, Sunita Dewnani, Steven A Spronk, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 231) with videos related to
Sort By:
Page
of 24
Journal of Medicinal Chemistry
|
June 17, 2016
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1)
John L Gilmore, James E Sheppeck, Scott H Watterson, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 9, 2016
Identification and synthesis of potent and selective pyridyl-isoxazole based agonists of sphingosine-1-phosphate 1 (S1P1)
Junqing Guo, Scott H Watterson, Steven H Spergel, et al.
Journal of Medicinal Chemistry
|
March 10, 2009
Novel tricyclic inhibitors of IkappaB kinase
James Kempson, Steven H Spergel, Junqing Guo, et al.
Journal of Medicinal Chemistry
|
May 17, 2002
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity
T G Murali Dhar, Zhongqi Shen, Junqing Guo, et al.
Scientific Reports
|
March 4, 2025
Author Correction: Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension
Shan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Scientific Reports
|
June 8, 2024
Discovery of RXFP2 genetic association in resistant hypertensive men and RXFP2 antagonists for the treatment of resistant hypertension
Shan-Shan Zhang, Lance Larrabee, Andrew H Chang, et al.
Journal of Medicinal Chemistry
|
July 19, 2019
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
Stephen T Wrobleski, Ryan Moslin, Shuqun Lin, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products
J V Duncia, J B Santella, C A Higley, et al.
Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies
|
November 5, 2013
Aging as accelerated accumulation of somatic variants: whole-genome sequencing of centenarian and middle-aged monozygotic twin pairs
Kai Ye, Marian Beekman, Eric-Wubbo Lameijer, et al.
Journal of Medicinal Chemistry
|
April 3, 2026
Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease
Heidi L Perez, Sunita Dewnani, Steven A Spronk, et al.
Page
of 24